RRM2 and neoplasm: RRM2 expression levels were found to escalate with advancing tumor stage (Kruskal-Wallis test, p=2.273×10-33), and correlated strongly with TNM-T classification (p=1.08×10-31), suggesting its role in metastatic progression (Figures 1C, D).